Because of its association with T cell activation and transmigration, we hypothesized increased CD99 expression in MS patients, which could be a driver of an overall higher inflammatory state, but we did not find any significant differences between MS patients and healthy individuals in the peripheral blood. This evidence concerns the gene CD99 and myeloid sarcoma.